Fact CheckerSign in

NCT03497637Active, not recruiting

Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses

Comparison of Non-Invasive Vessel Fractional Flow Reserve Calculated From Angiographic Images Versus Fractional Flow Reserve in Patients With Intermediate Coronary Artery Stenoses

Source: ClinicalTrials.gov · Last updated 29 Oct 2026

Brief summary (registry, in English)

This is a prospective, randomized, controlled, multicenter, open-label study designed to assess whether vFFR is non-inferior to FFR in assessment of intermediate coronary stenosis in terms of the occurrence of MACE during 12 months after randomization.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
1054 (actual)
First submitted
6 Apr 2018
Start date
20 Jun 2020
Primary completion date
12 Feb 2026
Lead sponsor
Helios Health Institute GmbH
NCT number
NCT03497637

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1054
  • From 20 Jun 2020 to the primary completion date, 12 Feb 2026
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous CABG with patent grafts to the interrogated vessel

Other illness

  • Terminal disease with life expectancy of less than 12 months
  • Severe valvular heart disease requiring intervention/surgery

Other

  • Tandem stenoses separated by more than 10 mm that require separate pressure guide wire interrogation or PCI (not to be interrogated or treated as a single stenosis)
  • Total coronary occlusions
  • Hemodynamic instability (Killip class III-IV)
  • Heavily calcified or tortuous vessels
  • STEMI within 24 hours of procedure
  • ACS patients with difficulty in assessing the culprit lesion
  • Significant contraindication to adenosine administration (e.g. Asthma bronchiale)
  • Pregnancy

Who the study is looking for

  • Age \>18 years
  • Willing to participate and able to understand, read and sign the informed consent document before the planned procedure
  • Eligible for coronary angiography and/or PCI
  • Coronary artery disease in one or more native major epicardial vessels or their branches by coronary angiogram with visually assessed de novo coronary stenosis in which the physiological severity of the lesion is in question (typically 40-90% diameter stenosis).
  • Stable angina or acute coronary syndrome (non-culprit vessels only and outside of primary intervention during acute STEMI or NSTE-ACS)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Heart Center Dresden - University Clinic
Coordinator of this site? Confirm its status
DresdenGermanyUnknown status
University Clinic Erlangen
Coordinator of this site? Confirm its status
ErlangenGermanyUnknown status
Universitätsklinikum Essen
Coordinator of this site? Confirm its status
EssenGermanyUnknown status
University Clinic Giessen and Marburg
Coordinator of this site? Confirm its status
GiessenGermanyUnknown status
Herzzentrum Leipzig
Coordinator of this site? Confirm its status
LeipzigGermanyUnknown status
University Clinic Leipzig
Coordinator of this site? Confirm its status
LeipzigGermanyUnknown status
Klinikum der Stadt Ludwigshafen
Coordinator of this site? Confirm its status
LudwigshafenGermanyUnknown status
Lukaskrankenhaus Neuss
Coordinator of this site? Confirm its status
NeussGermanyUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.